Recap: PolarityTE Q3 Earnings

Shares of PolarityTE PTE moved higher by 7.3% in pre-market trading after the company reported Q3 results.

Quarterly Results

Earnings per share increased 79.31% over the past year to ($0.18), which beat the estimate of ($0.21).

Revenue of $3,337,000 higher by 139.21% from the same period last year, which beat the estimate of $2,970,000.

Looking Ahead

Earnings guidance hasn't been issued by the company for now.

PolarityTE hasn't issued any revenue guidance for the time being.

Conference Call Details

Date: Nov 09, 2020

Time: 08:00 AM

ET Webcast URL: https://event.webcasts.com/starthere.jsp?ei=1392187&tp_key=366f166ce8

Recent Stock Performance

52-week high: $4.60

Company's 52-week low was at $0.78

Price action over last quarter: down 32.24%

Company Description

PolarityTE Inc is a commercial-stage biotechnology and regenerative biomaterials company. Its focused on transforming the lives of patients by discovering, designing and developing regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering and material sciences. Its product includes SkinTE used for repair, reconstruction, replacement or regeneration of skin in patients who have or require treatment of acute and chronic wounds, burns, surgical reconstruction events, scar revision, or removal of dysfunctional skin grafts. It operates in two segments: the regenerative medicine business segment and the contract research segment.